Martek Revenue Could Double, Reach $90 Mil. In FY 2003, CEO Says
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences expects to double its penetration in both domestic and international infant formula markets by next year, company execs said during a June 6 analysts' call